The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia

Increasing knowledge concerning the biology of hematologic malignancies as well as the role of the immune system in the control of these diseases has led to the development and approval of immunotherapies that are resulting in impressive clinical responses. Therefore, the Society for Immunotherapy o...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Justin Kline, Ronald Levy, Joshua Brody, James N. Kochenderfer, Edmund K. Waller, Sundar Jagannath, Michael R. Bishop, David Siegel, David Avigan, Michael Boyiadzis, Jeffrey Miller, Rafat Abonour, Kenneth C. Anderson, Stephen M. Ansell, Lisa Barbarotta, Austin John Barrett, Koen Van Besien, P. Leif Bergsagel, Ivan Borrello, Jill Brufsky, Mitchell Cairo, Ajai Chari, Adam Cohen, Jorge Cortes, Stephen J. Forman, Jonathan W. Friedberg, Ephraim J. Fuchs, Steven D. Gore, Brad S. Kahl, Larry W. Kwak, Marcos de Lima, Mark R. Litzow, Anuj Mahindra, Nikhil C. Munshi, Robert Z. Orlowski, John M. Pagel, David L. Porter, Stephen J. Russell, Karl Schwartz, Margaret A. Shipp, Richard M. Stone, Martin S. Tallman, John M. Timmerman, Frits Van Rhee, Ann Welsh, Michael Werner, Peter H. Wiernik, Madhav V. Dhodapkar
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2016-12-01
coleção:	Journal for ImmunoTherapy of Cancer
Acesso em linha:	https://jitc.bmj.com/content/4/1/90.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!